HLIOMEDIUM SIGNALFINANCIAL10-K

HLIO shows mixed financial performance with declining revenue and operating income offset by improved cash position and reduced debt levels.

The company appears to be managing through a softer demand environment while strengthening its balance sheet, as evidenced by debt reduction and cash accumulation despite revenue headwinds. The disconnect between declining operating income yet improved net income suggests potential non-operating benefits or one-time gains that warrant closer examination.

Comparing 2026-03-03 vs 2025-02-25View on EDGAR →
FINANCIAL ANALYSIS

HLIO's financial profile reflects a company navigating operational challenges while improving its capital structure. Revenue declined 11.8% and operating income fell 19.3%, indicating core business pressures, yet net income grew 24.1% suggesting non-operating tailwinds. The balance sheet strengthened meaningfully with cash rising 65.5% to $73.0M and total debt reduced 18.3% to $368.0M, positioning the company with improved financial flexibility despite near-term operational headwinds.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+65.5%
$44.1M$73.0M

Cash position surged 65.5% — strong cash generation or capital raise providing significant financial cushion.

Net Income
P&L
+24.1%
$39.0M$48.4M

Net income grew 24.1% — bottom-line growth signals improving overall business health.

Operating Income
P&L
-19.3%
$81.8M$66.0M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Total Debt
Balance Sheet
-18.3%
$450.6M$368.0M

Debt reduced 18.3% — deleveraging strengthens balance sheet and reduces financial risk.

Revenue
P&L
-11.8%
$227.7M$200.7M

Revenue softened 11.8% — monitor whether this is cyclical or structural.

Accounts Receivable
Balance Sheet
+10.9%
$104.6M$116.0M

Receivables grew 10.9% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-03-03
PRIOR — 2025-02-25
ADDED
10-K --01-03 false FY 0001024795 P3M http://www.heliostechnologies.com/20260103#OtherAccruedExpensesAndCurrentLiabilities http://www.heliostechnologies.com/20260103#OtherAccruedExpensesAndCurrentLiabilities http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#Liabilities http://fasb.org/us-gaap/2025#Liabilities May 31, 2023 May 31, 2023 October 31, 2024 December 31, 2024 Jun.
The Registrant had 33,107,113 shares of common stock, par value $.001, outstanding as of February 20, 2026.
Management's Discussion and Analysis of Financial Condition and Results of Operations 37 Item 7A.
The Hydraulics segment designs and manufactures hydraulic motion control and fluid conveyance technology products, including cartridge valves, manifolds and quick release couplings as well as engineers complete hydraulic system solutions.
Our Shared Values At Helios, our shared values define how we show up for our customers, our colleagues, and our shareholders every day.
+7 more — sign up free →
REMOVED
The Registrant had 33,296,057 shares of common stock, par value $.001, outstanding as of February 14, 2025.
Management's Discussion and Analysis of Financial Condition and Results of Operations 36 Item 7A.
BUSINESS Our Business Overview and Strategy Helios Technologies, Inc.
The Hydraulics segment designs and manufactures hydraulic motion control and fluid conveyance technology products, including cartridge valves, manifolds and quick release couplings as well as engineers complete hydraulic system solutions and in some cases complete systems.
We are a global operating company and the framework of the Helios Business System, ( HBS ) (pictured below), is at the heart of all we do.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →